Status: Not yet recruiting
STOMP OUT: A Phase 2 Study To Evaluate The Effects Of Ivonescimab In Patients With Unresectable/Metastatic Adrenocortical Carcinoma (ACC) Or Unresectable Pheochromocytoma/Paraganglioma (PPGL)
To learn if ivonescimab can help to control previously treated, locally advanced or metastatic ACC or PPGL.
Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Aug 3, 2026Locations: 1
Eligibility criteria
18 years of age or older. Because no dosing or adverse event data are currently... [+20]
Received cytotoxic chemotherapy (including investigational cytotoxic chemotherap... [+46]